MiniMed Group, Inc. Common Stock (MMED)
MiniMed Group, Inc. Common Stock operates in the Medical - Equipment & Services industry of the Healthcare sector, headquartered in Northridge, CA, US. The stock last traded at $19.73, down 1.07% on the session, giving a market capitalisation of $5.54B. On trailing twelve-month figures it carries a trailing P/E of -17.93, a net margin of -21.7%. Its beta of -3.68 implies it has historically moved less than the broad market.
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.